Vol. 51 | No. 2 | July-December 2023 Back

Open Access

Commentary on “The Management of Atrial Fibrillation in the Philippines: A State-of-the-Art Review”

Noemi S. Pestaño
Dec 2023 DOI 10.69944/pjc.159b462bc9

Abstract

The 2022 annual report of the Asia Pacific Heart Rhythm Society reported that the prevalence of atrial fibrillation (AF) in the Philippines from 2018 to 2021 was between 0.20%-0.40%.1

This prevalence is expected to inflate unless measures are adapted for its early screening, diagnosis and compendious management. Through the years, approaches to the management of atrial fibrillation have undergone evolutionary change. Dr. Erdie Fadreguilan has discussed the evidences in his article “The Management of Atrial Fibrillation in the Philippines: A State-of-the-Art Review”. It underscores the succinct strategies to curtail the progression of paroxysmal AF to persistent one and attenuate the complications caused by AF.

References
  1. Asia Pacific Heart rhythm Society white Book 2022.  https://www.aphrs.org/attachment/article/42/APHRS%20 White%20Book%202022.pdf. Accessed 23 July 2023. 
  2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC  guidelines for the diagnosis and management of atrial  fibrillation developed in collaboration with the European  Association for Cardio-Thoracic Surgery (EACTS): the  task force for the diagnosis and management of atrial  fibrillation of the European Society of Cardiology (ESC).  Developed with the special contribution of the European  Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42(5):373–498. https://doi.org/10. 1093/eurheartj/ ehaa612.  
  3. Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser  SH, Ma CS, Natale A, Turakhia MP, Kirchhof P. The  Increasing Role of Rhythm Control in Patients With Atrial  Fibrillation: JACC State-of-the-Art Review. J Am Coll  Cardiol 2022 May 17;79(19):1932-1948. doi: 10.1016/j. jacc.2022.03.337. PMID: 35550691. 
  4. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter  Ablation vs Antiarrhythmic Drug Therapy on Mortality,  Stroke, Bleeding, and Cardiac Arrest Among Patients  With Atrial Fibrillation: The CABANA Randomized Clinical  Trial. JAMA 2019;321(13):1261–1274. doi:10.1001/ jama.2019.0693 
  5. Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control  therapy in patients with atrial fibrillation. N Engl J Med 2020;383:1305–1316. 
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.